Breaks Categories: News

TuesdaySep 12, 2017 1:19 pm

NetworkNewsBreaks – VirTra, Inc. (VTSI) Files Preliminary Offering Circular with the SEC; Inks Deal with US Department of Homeland Security

VirTra (OTCQX: VTSI) recently filed a preliminary offering circular with the Securities and Exchange Commission (SEC) pursuant to the Regulation A framework, which is open to both accredited and unaccredited investors. The company also intends to file an application to uplist its common stock on the NASDAQ Capital Market under the symbol VTSI. The intent in filing is to raise gross proceeds of between $5 million and $10 million by permitting the company to issue new shares of common stock. Boustead Securities, LLC is serving as underwriter for the company. "This potential offering and the launch of our uplisting efforts are…

Continue Reading

TuesdaySep 12, 2017 1:16 pm

NetworkNewsBreaks – Aethlon Medical, Inc. (NASDAQ: AEMD) Shares Skyrocket on EAP Designation from FDA on Hemopurifier® to Treat Life-Threatening Viruses

Shares of Aethlon Medical’s (NASDAQ: AEMD) stock are up 49% after the company this morning said it has received an Expedited Access Pathway (EAP) designation from the United States Food and Drug Administration (FDA) to support the advancement of the Aethlon Hemopurifier® to treat life-threatening viruses. Receiving EAP designation grants the company support from the FDA by working with the company to reduce the time and cost from development to marketing. "We are honored to have our Hemopurifier® designated to the Expedited Access Pathway and additionally are pleased that FDA has also allowed our proposed "indication for use," which provides…

Continue Reading

TuesdaySep 12, 2017 12:53 pm

NetworkNewsBreaks – ProBility Media’s (PBYA) One Exam Prep Division Strengthens National Presence with Asset Purchase Agreement

EdTech innovator ProBility Media Corp. (OTCQB: PBYA), through its One Exam Prep division, today announced its entry into an asset purchase agreement with Contractor Exam Preps of Pittsboro, North Carolina. Per the company’s news release, this transaction is expected to immediately expand One Exam Prep’s position as a nationwide leader in exam prep for contractors and related licenses, including all NASCLA-related certifications. “One Exam Prep founder and President Rob Estell is a master instructor that has built the division into a powerhouse, from the ground up, and has taken the Company under ProBility to new levels,” Noah Davis, president and…

Continue Reading

TuesdaySep 12, 2017 10:19 am

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Records 76% YOY Increase in Revenues for FY2017

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced its financial results for the fiscal year ended May 31, 2017. Among the highlights, the company recorded a 76 percent increase in total operating revenues as compared to 2016. CIIX noted that both its investor relations business and its subscription business posted strong growth during the 12-month period, with revenues increasing by 130 percent and 57 percent, respectively. The company also provided an update on its outlook for fiscal year 2018. “Although the business of our Consumer Division is still in the early stages, the recently launched 'OptHemp' product line…

Continue Reading

TuesdaySep 12, 2017 9:52 am

NetworkNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Files Provisional Patent Covering Proprietary Biosynthesis Program

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its filing of a provisional patent application pertaining to the company’s biosynthesis program for the manufacture of cannabinoids that are identical to those found in nature. Per the news release, this patent application, once converted into an international Patent Cooperation Treaty (PCT) application and pursued in key jurisdictions around the world, will offer significant commercial protections for InMed’s promising E. coli-based expression system, which enables the manufacture of any of the 90+ cannabinoid compounds found in the cannabis plant. “This novel approach to the biosynthesis of…

Continue Reading

TuesdaySep 12, 2017 9:22 am

NetworkNewsBreaks – LottoGopher Holdings Inc. (OTCQB: LTTGF) (CSE: LOTO) (FRA: 2LG) Names William Shatner its Official Company Spokesman

LottoGopher Holdings Inc. (OTCQB: LTTGF) (CSE: LOTO) (FRA: 2LG), a provider of lottery ticket management solutions for consumers, this morning announced that actor, director, author and singer William Shatner has partnered with the company to become its new spokesman. Shatner is one of the most recognizable celebrities on the planet, known primarily for his memorable roles on shows like Star Trek, Boston Legal and T.J. Hooker. “I am very happy to be joining the LottoGopher team. Much like Netflix disrupted the movie rental business and Uber hailing a cab, LottoGopher is disrupting the lottery industry for Americans,” Shatner stated in…

Continue Reading

MondaySep 11, 2017 1:11 pm

NetworkNewsBreaks – Tetra Bio-Pharma (TSX.V: TBP) (OTCQB: TBPMF) Accelerates its Cannabis-based Clinical Research Program in the Veterinary Market

Tetra Bio-Pharma (TSX.V: TBP) (OTCQB: TBPMF), a biopharmaceutical leader in cannabinoid-based drug discovery and development, is adding international expert Dr. Louis-Philippe de Lorimier, a board certified veterinary oncologist, to its clinical advisory board for the veterinary market. In a news release, Dr. Guy Chamberland, chief scientific officer of Tetra Bio-Pharma, said, "We are leveraging our current R&D work in humans to accelerate the development of the first cannabinoid-based drug for pets in the cancer-associated supportive therapy market, including pain. This market is underserved and patients and their owner are waiting for alternatives that are safer, more tolerable and more efficacious.”…

Continue Reading

MondaySep 11, 2017 12:19 pm

NetworkNewsBreaks – Terra Tech Corp. (TRTC) Files Provisional Patent Application for Cannabis-Infused Rolling Papers

Terra Tech Corp. (OTCQX: TRTC), a vertically integrated, cannabis-focused agriculture company, has filed a patent application with the U.S. Patent and Trademark Office for innovative cannabis-infused rolling papers. Expected to launch in 2018, the inventive rolling papers will be the latest addition to the company’s portfolio of IVXX™ branded premium cannabis products, which includes flowers, concentrates, custom-rolled joints and edibles. As with all its products, the rolling papers will be free of toxic pesticides, harmful molds and chemical residues, the company states. In the news release, Derek Peterson, CEO of Terra Tech, said, “Infusing rolling papers with cannabis can enhance…

Continue Reading

MondaySep 11, 2017 10:04 am

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Retains Biopsy, LLC to Provide Leadership in Growth and E-Commerce

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced its retention of Biopsy, LLC, managed by bestselling author Chris J. Snook, to provide leadership in growth and e-commerce. Effective September 1, 2017, Biopsy, LLC will serve as the architect of the digital infrastructure and go-to-market strategy for ChineseInvestors.com, Inc. and its subsidiaries, reporting directly to the companies’ management teams. “ChineseInvestors.com, Inc. is fortunate to be able to contract with Biopsy, LLC as Chris' unique skill and experience will enhance the Company's ability to effectively emerge as a leader in the CBD Biotechnology Industry, while also strengthening and expanding the…

Continue Reading

MondaySep 11, 2017 9:10 am

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Provides Update on Data Linking THC to Decrease in Aβ40 Protein Production

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced compelling in vitro data compiled from genetically engineered cell lines showing that, at varying concentrations of THC, the production of Aβ40 protein decreases by as much as 50 percent over a 48-hour period. This is particularly noteworthy for patients with Alzheimer’s disease, as the condition often results in an imbalance of Aβ plaque that is believed to be toxic to nerve cells. This data, compiled by Dr. Chuanhai Cao, an IGC senior advisor and associate professor of pharmaceutical…

Continue Reading